HB Wealth Management, LLC

Position in SABS — SAB Biotherapeutics, Inc.

CIK 1911253 Atlanta, GA

Position in SABS

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,199,250

+$21,525 QoQ

Shares Held

307,500

0.0% QoQ

Ownership

0.338%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#30

of 87 holders

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HB Wealth Management, LLC holds $35,016,992 across 39 Biotechnology names. SABS ranks #5 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	50,440	$12,346,198
2	VRTX	Vertex Pharmaceuticals Inc / Ma	11,065	$5,496,317
3	REGN	Regeneron Pharmaceuticals, Inc.	2,712	$1,691,040
4	EXEL	Exelixis, Inc.	26,737	$1,454,760
5	SABS	SAB Biotherapeutics, Inc. This page	307,500	$1,199,250
6	RPRX	Royalty Pharma plc	20,240	$1,134,856
7	HALO	Halozyme Therapeutics, Inc.	14,202	$1,111,590
8	RVMD	Revolution Medicines, Inc.	5,336	$999,326

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,199,250	307,500	0.0%	Shares	Sole	2026-07-29
2026-03-31	$1,177,725	307,500	0.0%	Shares	Sole	2026-04-27
2025-12-31	$1,150,050	307,500	0.0%	Shares	Sole	2026-01-28
2025-09-30	$618,075	307,500	+16.8%	Shares	Sole	2025-10-23
2025-03-31 SABSW	—	60,000	+20.0%	Shares	Sole	2025-05-07
2025-03-31	$357,952	263,200	+10.9%	Shares	Sole	2025-05-07
2024-12-31 SABSW	—	50,001	-83.9%	Shares	Sole	2025-01-15
2024-12-31	$900,695	237,400	+118.6%	Shares	Sole	2025-01-15
2024-09-30 SABSW	—	310,000	—	Shares	Sole	2024-10-15
2024-09-30	$293,220	108,600	—	Shares	Sole	2024-10-15
No filing history on record for this holder in this stock.